BioBos L(6), Injekční suspenze
BioBos L(6), Injekční suspenze
Authorised
- Leptospira interrogans, Serogroup Pomona, Inactivated
- Leptospira interrogans, serogroup Sejroe, serovar Hardjo-prajitno, Inactivated
- Leptospira interrogans, serogroup Sejroe, serovar Hardjo-bovis, Inactivated
- Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
Product identification
Medicine name:
BioBos L(6), Injekční suspenze
Active substance:
- Leptospira interrogans, Serogroup Pomona, Inactivated
- Leptospira interrogans, serogroup Sejroe, serovar Hardjo-prajitno, Inactivated
- Leptospira interrogans, serogroup Sejroe, serovar Hardjo-bovis, Inactivated
- Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
Target species:
-
Cattle
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Leptospira interrogans, Serogroup Pomona, Inactivated16.00unit(s)1.00Dose
-
Leptospira interrogans, serogroup Sejroe, serovar Hardjo-prajitno, Inactivated35.00unit(s)1.00Dose
-
Leptospira interrogans, serogroup Sejroe, serovar Hardjo-bovis, Inactivated32.00unit(s)1.00Dose
-
Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated64.00unit(s)1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Cattle
-
Meat0day
-
Milk0hour
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AB03
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
- 96/021/11-C
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Labelling
This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?: